gvtcx

Pharmacogenomics as a Service - NW GMSA PROGRESS PROGRAMME

Manchester University NHS Foundation Trust Published 11 May 2023 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£119,880
Statuscomplete
Category (CPV) 48000000
Deadline12 Apr 2023
Contract start17 Apr 2023
Contract end16 Dec 2024
Procedureselective
SME suitableYes
OCIDocds-b5fd17-f3ac4aa4-d3d9-4f54-9de8-d3116804cc6e

Awards (2)

This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is £119,880.

SupplierValueDateStatus
Clinical Architecture Limited £268,488 22 Oct 2024 active
CLINICAL ARCHITECTURE LIMITED £119,880 11 Apr 2023 active

description

The "Pharmacogenetics as a Service" component of the PROGRESS Programme, aims to develop a digital solution which allows the persistence and messaging of pharmacogenetic data. This will be performed in the context of an initial pilot as part of the wider PROGRESS Programme, but any solution should have the potential to scale across the NHS.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
11 May 2023 Award (award) · bf9b6348-bd31-474b-8875-6361b9b87bcf-637819
24 Dec 2024 Award (award) · b7874f4a-dd8a-45f6-9619-1fc554e1e917-813757

more from Manchester University NHS Foundation Trust

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.